In current studies, PSAT1 has been identified as an oncogene associated with metastasis and poor prognosis in various malignancies, including lung cancer, liver cancer, colorectal cancer, breast cancer, ovarian cancer, and endometrial cancer [6,22,23]. Here, PSAT1 is linked to ovarian carcinoma.